C. Munera

发表

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

M. Rowbotham, Z. Bhagwagar, J. Farrar, 2012, PAIN.

A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection.

R. Echols, C. Munera, A. Iravani, 1999, The Journal of antimicrobial chemotherapy.

Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain

Eric B. Laber, I. Lipkovich, Fan Wu, 2018, Statistics in medicine.

Enriched analgesic efficacy studies: an assessment by clinical trial simulation.

D. Stanski, D. R. Wada, C. Munera, 2006, Contemporary clinical trials.

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users

F. Menzaghi, L. Webster, J. Henningfield, 2021, Clinical and translational science.

Application site adverse events associated with the buprenorphine transdermal system: a pooled analysis

S. Ripa, C. Munera, R. Swanton, 2013, Expert opinion on drug safety.

Advantages of α-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients

P. Raskin, H. Lebovitz, D. Simonson, 1998 .

Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.

P. Raskin, H. Lebovitz, D. Simonson, 1998, The Journal of clinical endocrinology and metabolism.

A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis.

C. Munera, M. Drehobl, N. Sessler, 2010, Journal of opioid management.

Efficacy of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis of KALM-1 and KALM-2 Phase 3 Studies

F. Menzaghi, K. Mccafferty, T. Wooldridge, 2022, Kidney medicine.

Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients

F. Menzaghi, R. Spencer, M. Kashif, 2020, Kidney international reports.

A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.

F. Menzaghi, S. Fishbane, C. Munera, 2019, The New England journal of medicine.

Dose‐Dependent Flux of Buprenorphine Following Transdermal Administration in Healthy Subjects

C. Munera, S. Harris, A. Cipriano, 2016, Journal of clinical pharmacology.

Safety and Effectiveness of Difelikefalin in Patients With Moderate-to-Severe Pruritus Undergoing Hemodialysis: An Open-Label, Multicenter Study

M. Vervloet, F. Menzaghi, D. Weiner, 2022, Kidney medicine.

Buprenorphine transdermal system compared with placebo reduces interference in functioning for chronic low back pain

R. Raffa, J. Pergolizzi, A. Yarlas, 2015, Postgraduate medicine.

Efficacy and safety of the seven-day buprenorphine transdermal system in opioid-naïve patients with moderate to severe chronic low back pain: an enriched, randomized, double-blind, placebo-controlled study.

S. Ripa, C. Munera, G. Sawyerr, 2011, Journal of pain and symptom management.

Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.

S. Ripa, C. Munera, M. Hale, 2011, The journal of pain : official journal of the American Pain Society.

Safety and Tolerability of Difelikefalin for the Treatment of Moderate to Severe Pruritus in Hemodialysis Patients: Pooled Analysis From the Phase 3 Clinical Trial Program

F. Menzaghi, S. Fishbane, K. Mccafferty, 2022, Kidney medicine.

Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus

R. Speck, F. Menzaghi, R. Spencer, 2021, Journal of Patient-Reported Outcomes.

Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.

R. Bissonnette, C. Munera, Brian S. Kim, 2023, The New England journal of medicine.

Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.

S. Ripa, C. Munera, N. Sessler, 2007, Clinical therapeutics.

A Subgroup Analysis Found no Diminished Response to Buprenorphine Transdermal System Treatment for Chronic Low Back Pain Patients Classified with Depression

R. Raffa, J. Pergolizzi, A. Yarlas, 2016, Pain practice : the official journal of World Institute of Pain.

Understanding the patient experience of living with notalgia paresthetica: A qualitative interview study

Rozanne Wilson, B. Currie, E. Bacci, 2022, JAAD International.

Effect of difelikefalin, a selective kappa opioid receptor agonist, on respiratory depression: A randomized, double‐blind, placebo‐controlled trial

E. Viscusi, M. Torjman, Joseph W. Stauffer, 2021, Clinical and translational science.

Clinically Meaningful Change in Itch Intensity Scores: an Evaluation in Patients with Chronic Kidney Disease-associated Pruritus.

F. Menzaghi, R. Spencer, S. Ständer, 2020, Journal of the American Academy of Dermatology.

A randomized, 14-day, double-blind study evaluating conversion from hydrocodone/acetaminophen (Vicodin) to buprenorphine transdermal system 10 μg/h or 20 μg/h in patients with osteoarthritis pain

B. Mccarberg, S. Ripa, C. Munera, 2012, Expert opinion on pharmacotherapy.

Effect of interferon gamma on infection-related death in patients with severe injuries. A randomized, double-blind, placebo-controlled trial.

F. Lewis, T. Clemmer, D. Trunkey, 1994, Archives of surgery.

The Burden of Pruritus Associated With CKD: A Mixed Methods Analysis Among Patients Undergoing Dialysis

F. Menzaghi, R. Spencer, C. Munera, 2023, Kidney medicine.

S. Ripa, C. Munera, C. Landau, 2011, Journal of pain and symptom management.

Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study.

S. Ripa, C. Munera, M. Hale, 2011, The journal of pain : official journal of the American Pain Society.